NASDAQ:ARQT | Insider Transactions — Page 3 | Arcutis Biotherapeutics, Inc.

ARQT Insider Transactions — Page 3

414 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 201–300; provenance stays internal.

Insider profileRoleDateTransactionSharesPrice
Matsuda MasaruSee Remarks2023-03-02Sale18.0$16.52
Matsuda MasaruSee Remarks2023-03-02Sale1,416.0$15.82
Burnett PatrickSee Remarks2023-03-02Sale23.0$16.52
Burnett PatrickSee Remarks2023-03-02Sale1,728.0$15.82
Turney Patricia A.SVP, Operations2023-03-02Sale18.0$16.52
Turney Patricia A.SVP, Operations2023-03-02Sale1,414.0$15.82
Watanabe Todd FranklinSee Remarks2023-03-02Sale69.0$16.52
Watanabe Todd FranklinSee Remarks2023-03-02Sale5,403.0$15.82
Burrows Scott LChief Financial Officer2023-03-02Sale18.0$16.52
Burrows Scott LChief Financial Officer2023-03-02Sale1,416.0$15.82
Lock Kenneth A.Chief Commercial Officer2023-03-02Sale18.0$16.52
Lock Kenneth A.Chief Commercial Officer2023-03-02Sale1,414.0$15.82
OSBORNE DAVID WChief Technical Officer2023-03-02Sale15.0$16.52
OSBORNE DAVID WChief Technical Officer2023-03-02Sale1,198.0$15.82
Turney Patricia A.SVP, Operations2023-02-28Sale936.0$16.17
Watanabe Todd FranklinSee Remarks2023-02-28Sale2,343.0$16.17
Burrows Scott LChief Financial Officer2023-02-28Sale416.0$16.17
Lock Kenneth A.Chief Commercial Officer2023-02-28Sale936.0$16.17
OSBORNE DAVID WChief Technical Officer2023-02-28Sale792.0$16.17
Welgus Howard G.Director2023-02-15Sale8,500.0$16.98
Watanabe Todd FranklinSee Remarks2023-02-14Sale100.0$17.03
Watanabe Todd FranklinSee Remarks2023-02-14Sale417.0$17.02
Watanabe Todd FranklinSee Remarks2023-02-13Sale42.0$17.01
Watanabe Todd FranklinSee Remarks2023-02-13Sale441.0$17.0
Watanabe Todd FranklinSee Remarks2023-02-01Sale382.0$17.0
Watanabe Todd FranklinSee Remarks2023-02-01Sale618.0$17.0
Welgus Howard G.Director2023-01-17Sale8,500.0$13.72
Burnett PatrickSee Remarks2023-01-03Sale1,475.0$15.01
Watanabe Todd FranklinSee Remarks2022-12-07Sale1,000.0$17.06
Matsuda MasaruSee Remark2022-11-21Sale1,720.0$18.19
Welgus Howard G.Director2022-11-15Sale3,403.0$20.01
Watanabe Todd FranklinSee Remarks2022-11-07Sale1,000.0$18.0
Watanabe Todd FranklinPresident and CEO2022-10-07Sale1,000.0$19.51
Welgus Howard G.Director2022-10-04Sale6,000.0$20.29
Watanabe Todd FranklinPresident and CEO2022-09-07Sale1,000.0$21.51
Welgus Howard G.Director2022-08-15Sale6,000.0$24.8
Watanabe Todd FranklinPresident and CEO2022-08-05Sale2,500.0$24.74
Topper James NTenPercentOwner2022-08-05Purchase250,000.0$20.0
Heron Patrick JDirector,TenPercentOwner2022-08-05Purchase250,000.0$20.0
Frazier Life Sciences VIII, L.P.TenPercentOwner2022-08-05Purchase250,000.0$20.0
FHM LIFE SCIENCES VIII, L.P.TenPercentOwner2022-08-05Purchase250,000.0$20.0
FHM LIFE SCIENCES VIII, L.L.C.TenPercentOwner2022-08-05Purchase250,000.0$20.0
Welgus Howard G.Director2022-07-18Sale6,000.0$24.4
OSBORNE DAVID WChief Technical Officer2022-07-08Sale2,197.0$25.41
Watanabe Todd FranklinPresident and CEO2022-07-08Sale7,087.0$25.41
Watanabe Todd FranklinPresident and CEO2022-07-08Sale4,913.0$25.41
Watanabe Todd FranklinPresident and CEO2022-07-08Sale1,500.0$25.0
Watanabe Todd FranklinPresident and CEO2022-07-06Sale1,000.0$22.07
ORBIMED ADVISORS LLCTenPercentOwner2022-06-24Sale35,944.0$21.31
ORBIMED CAPITAL LLCTenPercentOwner2022-06-24Sale35,944.0$21.31
OrbiMed Capital GP VII LLCTenPercentOwner2022-06-24Sale35,944.0$21.31
ORBIMED ADVISORS LLCTenPercentOwner2022-06-24Sale306,027.0$21.31
ORBIMED CAPITAL LLCTenPercentOwner2022-06-24Sale306,027.0$21.31
OrbiMed Capital GP VII LLCTenPercentOwner2022-06-24Sale306,027.0$21.31
Watanabe Todd FranklinPresident and CEO2022-06-06Sale1,000.0$21.06
Matsuda MasaruSVP and General Counsel2022-06-02Sale1,795.0$19.73
Welgus Howard G.Director2022-06-01Sale2,500.0$20.62
Watanabe Todd FranklinPresident and CEO2022-05-05Sale1,000.0$21.76
Welgus Howard G.Director2022-05-02Sale2,500.0$20.44
OSBORNE DAVID WChief Technical Officer2022-04-21Sale2,197.0$20.42
ORBIMED ADVISORS LLCTenPercentOwner2022-04-08Sale102,800.0$20.71
ORBIMED CAPITAL LLCTenPercentOwner2022-04-08Sale102,800.0$20.71
OrbiMed Capital GP VII LLCTenPercentOwner2022-04-08Sale102,800.0$20.71
ORBIMED ADVISORS LLCTenPercentOwner2022-04-08Sale97,200.0$20.71
ORBIMED CAPITAL LLCTenPercentOwner2022-04-08Sale97,200.0$20.71
OrbiMed Capital GP VII LLCTenPercentOwner2022-04-08Sale97,200.0$20.71
ORBIMED ADVISORS LLCTenPercentOwner2022-04-07Sale177,196.0$20.66
ORBIMED CAPITAL LLCTenPercentOwner2022-04-07Sale177,196.0$20.66
OrbiMed Capital GP VII LLCTenPercentOwner2022-04-07Sale177,196.0$20.66
ORBIMED ADVISORS LLCTenPercentOwner2022-04-07Sale167,800.0$20.66
ORBIMED CAPITAL LLCTenPercentOwner2022-04-07Sale167,800.0$20.66
OrbiMed Capital GP VII LLCTenPercentOwner2022-04-07Sale167,800.0$20.66
ORBIMED ADVISORS LLCTenPercentOwner2022-04-06Sale171,204.0$20.69
ORBIMED CAPITAL LLCTenPercentOwner2022-04-06Sale171,204.0$20.69
OrbiMed Capital GP VII LLCTenPercentOwner2022-04-06Sale171,204.0$20.69
ORBIMED ADVISORS LLCTenPercentOwner2022-04-06Sale162,000.0$20.69
ORBIMED CAPITAL LLCTenPercentOwner2022-04-06Sale162,000.0$20.69
OrbiMed Capital GP VII LLCTenPercentOwner2022-04-06Sale162,000.0$20.69
Watanabe Todd FranklinPresident and CEO2022-04-05Sale1,000.0$21.43
Welgus Howard G.Director2022-04-01Sale7,500.0$20.02
Watanabe Todd FranklinPresident and CEO2022-03-09Sale300.0$17.0
Watanabe Todd FranklinPresident and CEO2022-03-07Sale700.0$17.11
Watanabe Todd FranklinPresident and CEO2022-03-07Sale70.0$16.44
Burnett PatrickSee Remarks2022-03-07Sale30.0$16.44
Lock Kenneth A.Chief Commercial Officer2022-03-07Sale30.0$16.44
Burrows Scott LChief Financial Officer2022-03-07Sale10.0$16.44
Turney Patricia A.SVP, Operations2022-03-07Sale30.0$16.44
OSBORNE DAVID WChief Technical Officer2022-03-07Sale28.0$16.44
Watanabe Todd FranklinPresident and CEO2022-03-04Sale2,489.0$16.86
Burnett PatrickSee Remarks2022-03-04Sale981.0$16.86
Lock Kenneth A.Chief Commercial Officer2022-03-04Sale993.0$16.86
Burrows Scott LChief Financial Officer2022-03-04Sale293.0$16.86
Turney Patricia A.SVP, Operations2022-03-04Sale993.0$16.86
OSBORNE DAVID WChief Technical Officer2022-03-04Sale828.0$16.86
Watanabe Todd FranklinPresident and CEO2022-03-01Sale2,153.0$17.75
OSBORNE DAVID WChief Technical Officer2022-03-01Sale775.0$17.75
Burrows Scott LChief Financial Officer2022-03-01Sale420.0$17.75
Turney Patricia A.SVP, Operations2022-03-01Sale936.0$17.75
Lock Kenneth A.Chief Commercial Officer2022-03-01Sale935.0$17.75
Watanabe Todd FranklinPresident and CEO2022-02-09Sale1,000.0$17.0